These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25993309)

  • 1. Efficient access to novel androsteno-17-(1',3',4')-oxadiazoles and 17β-(1',3',4')-thiadiazoles via N-substituted hydrazone and N,N'-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro.
    Kovács D; Wölfling J; Szabó N; Szécsi M; Minorics R; Zupkó I; Frank É
    Eur J Med Chem; 2015 Jun; 98():13-29. PubMed ID: 25993309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facile access to novel steroidal 17-2'-(1',3',4')-oxadiazoles, and an evaluation of their cytotoxic activities in vitro.
    Kovács D; Mótyán G; Wölfling J; Kovács I; Zupkó I; Frank É
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1265-8. PubMed ID: 24518189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17α-hydroxylase/C₁₇,₂₀-lyase.
    Kovács D; Wölfling J; Szabó N; Szécsi M; Kovács I; Zupkó I; Frank E
    Eur J Med Chem; 2013; 70():649-60. PubMed ID: 24211641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel 17-(4'-formyl)pyrazolylandrosta-5,16-dienes and their derivatives as potent 17α-hydroxylase/C17,20-lyase inhibitors or antiproliferative agents depending on the substitution pattern of the heteroring.
    Kovács D; Wölfling J; Szabó N; Szécsi M; Schelz Z; Zupkó I; Frank É
    Eur J Med Chem; 2016 Sep; 120():284-95. PubMed ID: 27209562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of methoxycarbonylpyrazolylandrostene derivatives, and their potential inhibitory effect on androgen biosynthesis and cell proliferation.
    Szabó N; Iványi Z; Szécsi M; Julesz J; Mernyák E; Huber J; Wölfling J; Minorics R; Zupkó I; Schneider G
    Steroids; 2015 Jun; 98():143-52. PubMed ID: 25804762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide.
    Palekar VS; Damle AJ; Shukla SR
    Eur J Med Chem; 2009 Dec; 44(12):5112-6. PubMed ID: 19683841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents.
    Kumar D; Patel G; Chavers AK; Chang KH; Shah K
    Eur J Med Chem; 2011 Jul; 46(7):3085-92. PubMed ID: 21481985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave-assisted stereoselective approach to novel steroidal ring D-fused 2-pyrazolines and an evaluation of their cell-growth inhibitory effects in vitro.
    Mótyán G; Kovács F; Wölfling J; Gyovai A; Zupkó I; Frank É
    Steroids; 2016 Aug; 112():36-46. PubMed ID: 27154752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives).
    Hayat F; Salahuddin A; Zargan J; Azam A
    Eur J Med Chem; 2010 Dec; 45(12):6127-34. PubMed ID: 20961670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors.
    Rajak H; Agarawal A; Parmar P; Thakur BS; Veerasamy R; Sharma PC; Kharya MD
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5735-8. PubMed ID: 21875796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
    Kumar D; Maruthi Kumar N; Chang KH; Shah K
    Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole Acyclic Sugar Derivatives.
    Kassem AF; Nassar IF; Abdel-Aal MT; Awad HM; El-Sayed WA
    Chem Pharm Bull (Tokyo); 2019; 67(8):888-895. PubMed ID: 31366838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety.
    Zhang K; Wang P; Xuan LN; Fu XY; Jing F; Li S; Liu YM; Chen BQ
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5154-6. PubMed ID: 25442303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
    Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors.
    Jin XY; Chen H; Li DD; Li AL; Wang WY; Gu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):955-972. PubMed ID: 31072147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide.
    Terzioglu N; Gürsoy A
    Eur J Med Chem; 2003; 38(7-8):781-6. PubMed ID: 12932910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
    Revelant G; Gadais C; Mathieu V; Kirsch G; Hesse S
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2724-7. PubMed ID: 24815511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective Synthesis, Synthetic and Pharmacological Application of Monoterpene-Based 1,2,4- and 1,3,4-Oxadiazoles.
    Gonda T; Bérdi P; Zupkó I; Fülöp F; Szakonyi Z
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.